New York - Adjuvant therapy with a macrophage-activating growth factor appears to prolong survival in high-risk melanoma, Lynn E. Spitler, M.D., said.
The Mainstream Patient: February 7
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
The Art of Smelling Good
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
The Weekly Roundup: January 30-February 3
Losing a Malpractice Case May Depend on Where You Live